Milestone Advisory Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-895
Closed -$237K 95
2021
Q4
$237K Hold
895
0.12% 80
2021
Q3
$259K Buy
+895
New +$230K 0.15% 73

Other funds holding RGEN

Milestone Advisory Partners's RGEN Position: Q1 2022 in Review

Milestone Advisory Partners sold out of Repligen (RGEN) in Q1 2022, closing a stake of 895 shares — an estimated $237K sold.

Milestone Advisory Partners first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $259K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Milestone Advisory Partners reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Milestone Advisory Partners sold 895 Repligen shares in Q1 2022, an estimated $237K.
  • Milestone Advisory Partners first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
  • Milestone Advisory Partners's Repligen position peaked at $259K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Milestone Advisory Partners's 13F filing for Q1 2022, filed 10 May 2022.